Skip to main content

Armistice Capital, Llc

Source: SEC Form 13F · as of Mar 2026

Armistice Capital, Llc holds 48 biotech & pharma companies tracked by BioSniper, totaling $1.17B in value as of Mar 2026 (SEC Form 13F).

Companies held

48

Total value held

$1.17B

BioSniper AIPage context preserved

Prepared research question

What matters most for Travere Therapeutics, Inc. (TVTX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
TVTXTravere Therapeutics, Inc.4,897,417$145.5M
PTCTPTC THERAPEUTICS, INC.2,074,449$141.3M
SUPNSUPERNUS PHARMACEUTICALS, INC.1,895,347$98.0M
AGIOAGIOS PHARMACEUTICALS, INC.2,716,000$91.9M
IMVTImmunovant, Inc.3,564,916$88.6M
INCYIncyte Corp.656,817$61.8M
CYTKCYTOKINETICS INC764,538$50.4M
NKTRNEKTAR THERAPEUTICS578,000$41.6M
IMCRImmunocore Holdings plc1,188,000$35.8M
IRONDisc Medicine, Inc.536,000$34.3M
KURAKura Oncology, Inc.3,736,000$30.4M
REGNREGENERON PHARMACEUTICALS, INC.36,126$27.9M
KALVKalVista Pharmaceuticals, Inc.1,236,000$24.9M
GRFSGrifols S.A.2,988,000$24.0M
SLDBSolid Biosciences Inc.3,200,000$23.0M
AUTLAutolus Therapeutics plc15,800,000$21.8M
ARVNARVINAS, INC.1,978,000$21.0M
FDMT4D Molecular Therapeutics, Inc.2,000,000$18.6M
SRRKScholar Rock Holding Corp336,959$16.6M
BCYCBICYCLE THERAPEUTICS PLC3,398,000$15.8M
SNYSanofi300,000$14.5M
VYGRVoyager Therapeutics, Inc.3,500,000$13.5M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)236,000$13.0M
BBOTBridgeBio Oncology Therapeutics, Inc.1,328,000$11.9M
XERSXeris Biopharma Holdings, Inc.1,909,838$11.1M
ESPREsperion Therapeutics, Inc.3,930,125$10.8M
SGMOQSANGAMO THERAPEUTICS, INC40,400,067$10.0M
ZURAZura Bio Ltd1,507,000$9.0M
TENXTENAX THERAPEUTICS, INC.478,827$7.7M
NUVBNuvation Bio Inc.1,736,000$7.4M
DWTXDogwood Therapeutics, Inc.3,280,000$6.9M
SYRESpyre Therapeutics, Inc.120,931$6.1M
CTORCITIUS ONCOLOGY, INC.9,188,855$5.7M
LCTXLineage Cell Therapeutics, Inc.3,182,799$5.0M
ESLAEstrella Immunopharma Inc.4,099,000$4.3M
NTLAIntellia Therapeutics, Inc.336,000$4.3M
PRTAPROTHENA CORP PUBLIC LTD CO439,411$4.3M
CRBPCorbus Pharmaceuticals Holdings, Inc.364,000$3.4M
KYNBKYNTRA BIO INC.400,000$2.7M
BTAIBioXcel Therapeutics, Inc.1,910,076$2.6M
SCLXSCILEX HOLDING CO297,706$2.0M
IMNNImunon, Inc.348,330$1.0M
OTLKOutlook Therapeutics, Inc.4,168,000$858K
RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC.592,079$432K
REVBREVELATION BIOSCIENCES, INC.323,241$388K
GOVXGeoVax Labs, Inc.269,253$372K
AKTXAkari Therapeutics Plc38,922$200K
PDSBPDS Biotechnology Corp173,605$105K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.